Comparison
Huperzine A vs Alpha-GPC
Huperzine A
Potent acetylcholinesterase inhibitor derived from Chinese club moss. Studied for Alzheimer's treatment in China.
Alpha-GPC
The most bioavailable common choline source. About 40% of an oral dose reaches the brain within an hour, where it serves as substrate for acetylcholine synthesis and as a phospholipid membrane component. The de facto pairing for every racetam stack.
| Field | Huperzine A | Alpha-GPC |
|---|---|---|
| Category | cholinergic | cholinergic |
| Dose range | 0.05–0.2mg | 300–600mg |
| Half-life | 12h | 6h |
| Onset | 60min | 30min |
| Evidence | EVIDENCEA | EVIDENCEA |
| Safety | ●●●○○ | ●●●●● |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 380 | 320 |
The comparison in plain English
Auto-generated from dataHuperzine A and Alpha-GPC are both in the cholinergic category respectively. Huperzine A Potent acetylcholinesterase inhibitor derived from Chinese club moss. Alpha-GPC The most bioavailable common choline source.
Bottom line
Huperzine A (evidence A, safety 3/5) matches the evidence base of Alpha-GPC (evidence A, safety 5/5). Alpha-GPC has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose Huperzine A if
Huperzine A is the better fit when your goal aligns with its mechanism (Reversibly inhibits acetylcholinesterase, preventing the breakdown of acetylcholine in synaptic clefts and prolonging cholinergic signalling) and the dose range (0.05–0.2mg) suits your protocol. Half-life is 12h.
Choose Alpha-GPC if
Alpha-GPC is the better fit when your goal aligns with its mechanism (Rapidly absorbed and cleaved into choline and glycerophosphate) and the dose range (300–600mg) suits your protocol. Half-life is 6h.